article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.

article thumbnail

European PFAS restriction could jeopardise pharmaceutical manufacturing

European Pharmaceutical Review

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Technology innovation aiding process spectroscopy market growth

European Pharmaceutical Review

A report by Spherical Insights has predicted that the process spectroscopy market will value $35.8 Importantly, spectroscopy techniques utilising molecular spectroscopy enable manufacturers to gain “real-time input on process parameters, which helps firms improve production processes, enhance productivity, and reduce costs”.

article thumbnail

Elevating pharmaceutical manufacturing processes with real-time insights

European Pharmaceutical Review

The race to develop new drugs and therapies demands rapid drug discovery, testing and time-to-market. To address these issues, companies should adopt more advanced production strategies such as continuous flow chemistry, as they can shorten manufacturing processes, increase productivity and throughput.

article thumbnail

Sustainable energy strategies for pharmaceutical manufacturers

European Pharmaceutical Review

This allows organisations to track data associated with the purchase, consumption and generation of energy including its impact on sustainability goals and environmental benefits using market and location-based emission calculations. About the author. Andrew Toher is Head of Customer Insights Europe at Enel X.

article thumbnail

Pharma unite to secure renewable energy in key manufacturing markets

European Pharmaceutical Review

This step is important as these countries are key markets for pharmaceuticals manufacturing. Based on data on sales/value-based shares from various companies for APIs and Chemicals, India and China are estimated to account for up to half of materials for medicines, the Sustainable Markets Initiative (SMI) noted.

article thumbnail

As pharma abandons the antibiotic market patients are at risk

World of DTC Marketing

A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market. They say that most drugmakers have exited the market because there is no money to be made while there is a lot of profit in new cancer drugs.

Pharma 174